Grant winners – 6 August 2015

A round-up of recent recipients of research council cash

August 6, 2015
Grant Winners header

Leverhulme Trust

Research Project Grants

Sequence-based stereochemical prediction: a new tool for polyketide structure elucidation

Individual energy budgets, life histories and population dynamics in the field

  • Award winner: Ben Collen
  • Institution: University College London
  • Value: £293,535

Predicting the dynamics of African ecosystems under multiple pressures

National Institute for Health Research

Health Technology Assessment programme

UK study of tendo Achilles rehabilitation multicentre randomised clinical trial (UK STAR)

Managing diabetes in people with dementia: a realist synthesis (DIaMonD)

Is it possible to develop a complex intervention to improve the outcome of fall-related injuries in people with dementia?

E-FREEZE: a randomised controlled trial evaluating the clinical and cost-effectiveness of a policy of freezing all embryos followed by thawed frozen embryo transfer, compared with a policy of fresh embryo transfer in women undergoing in vitro fertilization

Royal Society/Academy of Medical Sciences/British Academy

Newton Advanced Scholarships

The scheme provides researchers with a chance to develop the strengths of their research groups through collaboration and reciprocal visits with a UK partner

SUMOylation: novel neuroprotective approach for Alzheimer’s disease?

Countercurrent chromatography coupled with MS detection: tracking the large-scale isolation of target bioactive compounds to be used as starting material for the synthesis of new drug candidates

In detail

Bill and Melinda Gates Foundation

Award winner: Stuart Clarke
Institution: University of Southampton
Value: £370,000

A systematic analysis of global investments in pneumonia research

This project will analyse investments into infectious disease research – particularly pneumonia and maternal and neonatal infections – to better inform funding decisions. The team will look at how funding is allocated relative to the global burden of the disease and assess the outputs and impact of research. “We will quantify the contribution of research funds that these infections receive compared with research involving other pathogens that are important in human health. This will give policymakers a comprehensive picture of where there’s been a lack of funding relative to the impact of the disease and help to set global research investment priorities,” says Stuart Clarke, reader in infectious disease epidemiology and honorary consultant in health protection at the University of Southampton.

Please login or register to read this article.

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments


Featured jobs

Lecturer in Economics

Royal Holloway, University Of London

Math Faculty

Khalifa University